Editorial Volume 11, Issue 21 pp 9225—9226

CCL21 and prognosis in acute coronary syndrome

Thor Ueland1,3,4, , Pål Aukrust1,2,3, , Kenneth Caidahl5,6,7, ,

  • 1 Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
  • 2 Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
  • 3 Faculty of Medicine, University of Oslo, Oslo, Norway
  • 4 K.G. Jebsen-Thrombosis Research and Expertise Center (TREC), University of Tromsø, Tromsø, Norway
  • 5 Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • 6 Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden
  • 7 Departments of Molecular Medicine and Surgery and Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

Received: September 17, 2019       Published: November 6, 2019      

How to Cite

Copyright © 2019 Ueland et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.